Demand for Lactose in EU

Demand for Lactose in EU Size, Market Forecast and Outlook By FMI

The demand for lactose in eu was valued at USD 340.4 million in 2025, projected to reach USD 921.2 million in 2026, and is forecast to expand to USD 1.56 billion by 2036 at a 5.4% CAGR. The incremental revenue over the forecast period reflects steady demand from both food and pharmaceutical channels. Regular/full fat lactose leads at 38.6% share, reflecting the primary food-grade specification used in coffee creamers, ice cream, and bakery formulations where lactose provides mild sweetness, browning functionality, and bulk. Coffee-based drinks lead application at 47.8% share, driven by EU coffee consumption culture and the growing ready-to-drink coffee segment where lactose-containing creamers and flavoured milk additions are standard formulation inputs.

As per FMI, EU lactose supply is a derivative of the dairy processing chain, extracted from whey permeate during cheese and casein production. The EU is the world's largest dairy region, and its extensive cheese manufacturing base generates substantial whey streams from which lactose is crystallized and dried. Major lactose producers (FrieslandCampina, Lactalis, Arla, DMK) operate integrated dairy processing facilities where lactose is one of several value streams extracted from the same milk intake.

All major EU markets reflect differentiated growth. Netherlands at 5.8%, Rest of Europe at 5.7%, France at 5.6%, Spain at 5.5%, Italy at 5.3%, Germany at 5.2%. Netherlands sets the pace, while Germany registers steadier growth.

Summary of Demand for Lactose in EU

• Demand for Lactose in EU Definition
  • Lactose is a disaccharide sugar naturally present in mammalian milk, commercially extracted from whey permeate during cheese and casein manufacturing. It is supplied in food-grade (for coffee creamers, bakery, confectionery, infant formula) and pharmaceutical-grade (for tablet and capsule excipients) specifications, in crystalline monohydrate, anhydrous, and spray-dried formats.
• Demand Drivers in the Market
  • Coffee-based drink formulation demand: The EU ready-to-drink coffee and specialty coffee category is expanding at above-category growth rates, driving demand for lactose-containing creamers, flavoured milk additions, and sweetener systems where lactose provides browning, body, and mild sweetness at lower perceived sweetness than sucrose.
  • Pharmaceutical excipient baseline demand: Lactose remains the most widely used filler-binder excipient in oral solid dosage forms manufactured across EU pharmaceutical plants.
  • Infant formula lactose specification: EU infant formula manufacturers specify lactose as the primary carbohydrate source to match the composition of human breast milk, where lactose constitutes approximately 7% of total volume.
• Key Segments Analyzed in the FMI Report
  • Coffee-based Drinks: 47.8% share in 2026 by Application.
  • Regular/Full Fat: 38.6% share in 2026 by Product Type.
  • Netherlands: 5.8% compound growth, the fastest among tracked EU markets.
• Analyst Opinion at FMI
  • Nandini Roy Choudhury, Principal Consultant for Food & Beverage analysts observe that the EU lactose market is a co-product margin optimization story. Dairy processors who maximize lactose extraction and crystallization efficiency from their whey permeate streams capture incremental margin that subsidizes their overall dairy processing economics. The pharmaceutical-grade tier offers the highest per-kilogram returns but requires European Pharmacopoeia compliance investment that not all dairy processors are willing to make. Food-grade lactose demand is structurally stable but price-competitive, growing in line with EU food manufacturing output. The strategic risk for lactose-dependent formulators is supply volatility during dairy production downturns, which can cause price spikes of 20% to 40% in spot markets.
• Strategic Implications / Executive Takeaways
  • Procurement teams must map EU regulatory compliance pathways as classification, labelling, and specification rules vary by product grade and application.
  • Product development should evaluate multi-application positioning to capture value across food, pharmaceutical, and specialty channels from a single ingredient base.
  • Supply chain managers must diversify sourcing and maintain inventory buffers to mitigate concentration risk and seasonal supply gaps.

Demand for Lactose in EU Key Takeaways

Metric	Details
Industry Size (2026)	USD 921.2 million
Industry Value (2036)	USD 1.56 billion
CAGR (2026 to 2036)	5.4%

Source: Future Market Insights, 2026

Demand for Lactose in EU Definition

Lactose is a disaccharide sugar naturally present in mammalian milk, commercially extracted from whey permeate during cheese and casein manufacturing. It is supplied in food-grade (for coffee creamers, bakery, confectionery, infant formula) and pharmaceutical-grade (for tablet and capsule excipients) specifications, in crystalline monohydrate, anhydrous, and spray-dried formats.

Demand for Lactose in EU Inclusions

The report covers EU regional market sizes for lactose from 2026 to 2036. Segment analysis includes product type (regular/full fat, reduced fat), application (coffee-based drinks, smoothies and RTD, breakfast/cereal use, cooking and baking, other uses), distribution channel (food services, retail stores, online retail), and nature (conventional, organic). Country coverage includes Germany, France, Netherlands, Italy, Spain, and rest of Europe.

Demand for Lactose in EU Exclusions

The scope excludes lactose-free dairy products (which have lactose removed). Galacto-oligosaccharides (GOS) produced from lactose are excluded as a separate product category. Whey protein concentrates and isolates derived from the same dairy stream fall outside the analytical boundary.

Demand for Lactose in EU Research Methodology

• Primary Research: Structured interviews with procurement directors, formulation engineers, and regulatory affairs managers.
• Desk Research: Aggregated EU regulatory filings, trade publications, company reports, and Eurostat data.
• Market-Sizing and Forecasting: Bottom-up aggregation of production, import/export, and consumption with country-level pricing adjustments.
• Data Validation: Cross-validated against company disclosures and EU trade statistics.

Why is the Lactose Market Growing?

The sustained growth of the lactose market in EU stems from its multi-sector versatility, technological advancements, and strong regulatory foundations. Lactose’s ability to function as both a carbohydrate ingredient and a pharmaceutical excipient has cemented its place across three primary growth pillars: food and beverage applications, pharmaceutical formulations, and animal feed nutrition. Each of these sectors benefits from lactose’s intrinsic attributes its mild sweetness, good solubility, and bioavailability as well as EU’s unparalleled commitment to quality and safety.

Pharmaceutical-grade demand remains one of the central growth engines. Lactose monohydrate continues to dominate as a tablet filler and flow enhancer, used by leading drug manufacturers and contract development and manufacturing organizations (CDMOs). Its uniform particle size, compressibility, and chemical inertness make it indispensable in oral solid dosage formulations. As pharmaceutical manufacturing expands across Europe especially in Germany, Ireland, and France the reliance on EU-sourced lactose that meets Good Manufacturing Practice (GMP) standards grows stronger.

In the food and nutraceutical sector, lactose derivatives such as lactulose and galactose are increasingly valued for their prebiotic and metabolic benefits, contributing to digestive health and energy regulation. Rising consumer awareness of gut health, together with innovation in functional beverages and probiotic-enriched dairy alternatives, positions lactose as a natural additive compatible with health-conscious consumption patterns. On the production side, technological innovation in membrane filtration and enzymatic conversion enhances yield, purity, helping European processors optimize whey utilization a critical factor in EU’s circular dairy economy.

Segmental Analysis

Sales in the Lactose Market are segmented by form, derivative type, end use, distribution channel, grade, and region. By form, demand is divided into powder and granule, with powder dominating due to its extensive use in pharmaceutical excipients, infant formula, and food formulations. By derivative type, sales include monohydrate, galactose, lactulose, tagatose, and others, covering both functional and pharmaceutical applications.

End-use segments comprise food & beverage, pharmaceutical, animal feed, and others, reflecting lactose’s versatility. By distribution, direct to manufacturers, distributors/traders, and online B2B channels are included, with direct supply leading for quality and compliance. By grade, the market covers food, pharma, feed, and others. Regionally, demand spans Germany, France, Italy, Spain, the Netherlands, and Rest of Europe, EU’s core lactose hubs.

By Product Type (Derivative Type), Lactulose Segment Accounts for 38.6% Share

In 2025, the lactulose segment accounted for 38.6% of total EU lactose revenues, equivalent to USD 337.4 million, underscoring its leading role as a high-value derivative. By 2035, lactulose’s share is expected to rise to 40.0% (USD 594.3 million), driven by its extensive application in pharmaceutical laxatives, prebiotic supplements, and functional gut health products. Its physiological role as a non-digestible disaccharide makes it an important therapeutic agent for managing hepatic encephalopathy and constipation, ensuring continued medical demand. European manufacturers are expanding production of pharma-grade lactulose through optimized bioconversion and controlled crystallization systems that ensure compliance with stringent European Pharmacopoeia standards.

The monohydrate segment maintains steady performance with 30.0% market share in 2025 (USD 262.2 million) and 29.0% in 2035 (USD 430.9 million). It remains the cornerstone of pharmaceutical excipient production, used across tablet compression, capsule filling, and inhalation products. With the pharmaceutical industry’s transition toward continuous manufacturing and high-speed tablet presses, lactose monohydrate’s performance consistency and batch reproducibility sustain its indispensable role.

Galactose (15% in 2025) and tagatose (8% in 2025) together represent the innovation frontier of the market. Galactose is increasingly used in dairy-based sweeteners, infant nutrition, and functional foods, while tagatose has captured the attention of sugar reformulation initiatives due to its low-calorie, low-glycemic properties. Both segments illustrate the shift from commodity lactose to specialty carbohydrate derivatives offering specific metabolic or functional benefits.

By Application, Food and Beverage Accounts for 47.8% Share

In terms of application, food and beverage remains the largest segment, holding 47.8% share (USD 417.8 million) in 2025 and moderating slightly to 46.0% (USD 683.5 million) by 2035. EU’s strong dairy processing base, combined with innovation in infant formula, bakery, and functional beverages, underpins sustained lactose utilization. Manufacturers are increasingly emphasizing clean-label formulations, driving demand for lactose as a naturally sourced sweetener and texture enhancer. Moreover, as plant-based beverages expand, lactose derivatives such as galactose are being reformulated into hybrid dairy-alternative products to preserve sweetness profiles.

The pharmaceutical sector, representing 35.0% of EU demand in 2025 (USD 305.9 million), is forecast to rise to 36.0% (USD 534.9 million) by 2035. Lactose’s consistent particle size distribution, inertness, and compatibility with APIs make it the preferred excipient in tablet and capsule manufacturing. With continuous advancements in controlled-release dosage forms, lactose’s role as a formulation stabilizer is being further reinforced.

Animal feed applications (12.0% share) and other industrial uses (5.2%) will continue to offer niche opportunities. Lactose provides digestibility and energy density in young livestock nutrition, especially calf milk replacers and piglet feed.

Drivers, Restraints, and Key Trends

EU lactose market benefits from a unique convergence of industrial, technological, and regulatory drivers. The integration of dairy by-products into value-added ingredients aligns perfectly with EU’s circular economy agenda, ensuring that whey streams are not wasted but refined into high-value lactose and proteins. Pharmaceutical standardization, driven by EMA and European Pharmacopoeia regulations, further stimulates high-purity lactose demand.

The market faces structural restraints including volatile dairy input costs, shifts in infant formula regulations, and lactose intolerance awareness affecting consumer perception in specific regions. Producers are mitigating these risks through product diversification (into lactose-free or low-lactose formulations), strategic sourcing, and hedging contracts for dairy inputs.

Notable trends include the rise of biopharmaceutical lactose used in cell-culture media, digitally traceable ingredient labeling, and carbon-neutral dairy processing initiatives. As sustainability becomes a procurement criterion, European processors investing in renewable energy and waste valorization gain competitive advantage.

Europe Market Split by Country

EU lactose market sales are projected to grow from USD 874.0 million in 2025 to USD 1,478.8 million by 2035, registering a compound annual growth rate (CAGR) of 5.4% over the forecast period. Growth is supported by strong pharmaceutical excipient demand, expansion in infant nutrition and functional food production, and increasing adoption of high-purity lactose derivatives across European manufacturing hubs.

Germany maintains the largest share of EU lactose sales at 34.5% in 2025, driven by its advanced pharmaceutical manufacturing infrastructure, extensive dairy processing capacity, and consistent export performance. France follows with solid growth and continued innovation in nutraceuticals and pharma-grade ingredients. The Netherlands benefits from strong export orientation and high-value derivative production, while Italy and Spain contribute through functional food and feed applications. The Rest of Europe segment, including Ireland, Belgium, and Nordic countries, demonstrates steady expansion supported by growing dairy valorization initiatives and biopharmaceutical production.

Country	CAGR % (2025–2035)
Germany	5.2%
France	5.6%
Netherlands	5.8%
Italy	5.3%
Spain	5.5%
Rest of Europe	5.7%

Germany Leads European Sales with Pharmaceutical and Dairy Excellence

Revenue from lactose in Germany is projected to exhibit steady growth with a CAGR of 5.2% through 2035, driven by the country’s advanced pharmaceutical manufacturing infrastructure, high dairy processing capacity, and long-standing expertise in excipient-grade lactose production. Germany’s role as a central hub for pharma ingredient exports and functional dairy innovation continues to reinforce its dominance in EU lactose market.

Leading dairy and ingredient companies, including Milei GmbH, Meggle, and Arla Foods Ingredients, operate advanced purification facilities producing high-purity lactose and derivatives meeting stringent European Pharmacopoeia standards. German manufacturers leverage membrane filtration, chromatography, and spray-drying technologies to ensure consistent quality, supporting both domestic pharmaceutical formulation and export demand. Germany’s meticulous approach to quality, combined with its emphasis on sustainability and traceable sourcing, cements its leadership in EU lactose production and consumption.

Growth drivers:

• Established pharmaceutical infrastructure supporting excipient-grade lactose demand
• Strong dairy cooperatives enabling high-purity lactose production
• Sustainability and traceability focus enhancing export competitiveness

France Demonstrates Steady Growth with Infant Nutrition and Nutraceutical Expansion

Revenue from lactose in France is expanding at a CAGR of 5.6%, supported by the country’s globally recognized expertise in infant nutrition, dairy innovation, and nutraceutical formulation. France’s strong emphasis on food science and bio-innovation, along with a maturing pharma-nutritional crossover industry, continues to drive demand for lactose derivatives, including lactulose and galactose, which are widely used in digestive health and prebiotic products.

Major ingredient producers such as Lactalis Ingredients and Savencia Fromage & Dairy have expanded production capacity to meet both domestic and international demand for high-grade lactose ingredients. French lactose manufacturers also emphasize clean-label and natural formulation standards, aligning with growing consumer preference for transparent, sustainably sourced dairy ingredients. Demand benefits from France’s leadership in infant formula production, strong export channels, and increasing interest in functional lactose derivatives across dietary supplement applications.

Success factors:

• Leading role in infant formula and nutritional ingredient manufacturing
• Expansion of functional and prebiotic lactose derivatives
• Emphasis on clean-label, sustainable formulation trends

Italy Maintains Robust Growth with Functional Food Innovation

Revenue from lactose in Italy is growing at a CAGR of 5.3%, driven by expanding functional food production, increasing health-conscious consumer bases, and gradual modernization of the Italian dairy sector. Italy’s food manufacturing industry is adapting lactose into value-added applications such as functional dairy beverages, fortified bakery products, and nutraceutical formulations targeting gut and metabolic health.

Major processors, including Granarolo Group, Parmalat (Lactalis Italia), and FrieslandCampina Italy, have invested in advanced lactose recovery and purification systems that enhance production efficiency and quality. Italian food formulators are particularly focused on balancing traditional taste profiles with modern nutritional needs, integrating lactose derivatives like lactulose into wellness-oriented product lines. Italy’s lactose demand also benefits from growing nutraceutical brands, which use lactose as a carrier and stabilizer in dietary supplement tablets and powders.

Development factors:

• Expansion of functional and fortified food applications using lactose
• Growing wellness and nutraceutical product development
• Dairy modernization supporting high-purity lactose output

Spain Focuses on Industrial Modernization and Export Potential

Demand for lactose in Spain is projected to grow at a CAGR of 5.5%, supported by modernization in dairy processing, expanding nutritional product manufacturing, and rising pharmaceutical outsourcing activity. Spain’s dairy cooperatives and ingredient manufacturers are increasingly investing in high-efficiency lactose crystallization and drying technologies to improve output and meet international standards.

Leading Spanish producers, such as Corporación Alimentaria Peñasanta (CAPSA) and regional dairy processors, are scaling up lactose recovery operations from whey streams, emphasizing sustainability and circular dairy practices. Spain’s lactose market is also supported by the country’s growing export orientation, with manufacturers supplying lactose and its derivatives to the pharmaceutical and food industries in Latin America and North Africa. Rising health awareness among Spanish consumers is also driving lactose use in functional and sports nutrition products.

Growth enablers:

• Dairy sector modernization driving ingredient quality improvements
• Export expansion to Latin America and North Africa
• Functional food and supplement innovation increasing lactose utilization

Netherlands Emphasizes Innovation Leadership and Derivative Development

Demand for lactose in the Netherlands is expanding at the fastest CAGR of 5.8% among EU countries, fueled by the nation’s leadership in dairy innovation, ingredient research, and export-driven processing excellence. The Netherlands hosts several of Europe’s largest dairy cooperatives, including FrieslandCampina and DOC Kaas, which have developed advanced lactose production lines integrated with membrane filtration and bioconversion technologies.

The country’s strong R&D infrastructure and commitment to sustainable dairy valorization make it a prime innovation hub for new lactose derivatives such as tagatose and lactulose, which are used in low-glycemic foods and pharmaceutical applications. Dutch ingredient producers collaborate closely with universities and biotech firms to develop next-generation lactose derivatives that balance functional benefits with clean-label expectations. The Netherlands also leads in exporting high-purity lactose to Asia and North America.

Innovation drivers:

• Dairy innovation leadership promoting derivative development
• Bioconversion technologies supporting high-value lactose products
• Export-oriented processing with sustainability integration

Rest of Europe Strengthens Position with Biopharma and Sustainable Processing

Revenue from lactose in the Rest of Europe (including Ireland, Belgium, Austria, and Nordic countries) is projected to grow at a CAGR of 5.7%, reflecting accelerating investment in biopharmaceutical manufacturing, sustainable ingredient processing, and regional whey valorization projects. These markets are emerging as agile contributors to Europe’s lactose supply chain, emphasizing low-carbon production systems and traceable ingredient sourcing.

Ireland’s advanced dairy sector particularly through Glanbia Nutritionals is expanding pharma-grade lactose production for export to U.S. and APAC pharmaceutical companies. Nordic countries, led by Denmark and Finland, emphasize sustainable dairy practices and renewable-energy-based processing, ensuring low-emission lactose output. The region collectively supports Europe’s transition toward a green, technology-driven lactose industry, balancing volume growth with environmental responsibility.

Key strengths:

• Expanding biopharma-grade lactose production for export
• Sustainable processing powered by renewable energy
• Regional collaboration supporting circular dairy economy

Competitive Landscape

EU lactose market is characterized by competition among major dairy ingredient manufacturers, pharmaceutical excipient suppliers, and emerging derivative innovators. Companies are investing in advanced filtration technologies, enzymatic conversion, and sustainable dairy valorization to produce high-purity, compliant, and functionally specialized lactose products. Strategic integration with pharmaceutical producers, infant nutrition brands, and nutraceutical developers is central to maintaining competitiveness and meeting strict EU quality standards.

Lactalis Ingredients leads with around 9% market share, benefiting from its global ingredient expertise and strong pharma-grade lactose production. Arla Foods Ingredients follows with about 8% share, focusing on sustainability-driven lactose recovery and clean-label innovation. Kerry Group (6.5%) specializes in lactulose and tagatose derivatives for functional and low-glycemic formulations. Glanbia Nutritionals (5.5%) leverages pharmaceutical excipient expertise and high-purity manufacturing, while Milei GmbH (3.5%) excels in precision-driven pharma-grade lactose production.

Other companies collectively hold 67.5% share, reflecting a fragmented yet dynamic landscape with regional dairy cooperatives, biotechnology startups, and contract manufacturers entering the market. Competitive differentiation increasingly depends on purity standards, traceability systems, regulatory compliance, and sustainability credentials, as EU producers align with rising global demand for pharma-validated, functional, and environmentally responsible lactose solutions.

Key Players

• BASF SE
• Davisco Foods International Inc.
• Armor Pharma
• Hilmar Ingredients
• Hoogwegt Group B.V.
• Kerry Group Plc.
• India Limited
• Merck & Co. KgAa
• Milei GmbH
• Ba'emek Advanced Technologies Ltd.
• Others

Scope of the Report

Metric	Value
Quantitative Units	USD 921.2 million to USD 1.56 billion, CAGR 5.4%
Market Definition	Lactose is a disaccharide sugar naturally present in mammalian milk, commercially extracted from whey permeate during cheese and casein manufacturing. It is supplied in food-grade (for coffee creamers, bakery, confectionery, infant formula) and pharmaceutical-grade (for tablet and capsule excipients) specifications, in crystalline monohydrate, anhydrous, and spray-dried formats.
Segmentation	Product Type (Regular/Full Fat, Reduced Fat), Application (Coffee-based Drinks, Smoothies & RTD, Breakfast/Cereal Use, Cooking & Baking, Other Uses), Distribution Channel (Food Services, Retail Stores, Online Retail), Nature (Conventional, Organic)
Regions Covered	Europe (EU member states)
Countries Covered	Netherlands, Rest of Europe, France, Spain, Italy, Germany
Key Companies Profiled	BASF SE, Davisco Foods International Inc., Armor Pharma, Hilmar Ingredients, Hoogwegt Group B.V., Kerry Group Plc., India Limited, Merck & Co. KgAa, Milei GmbH, Ba'emek Advanced Technologies Ltd.
Forecast Period	2026 to 2036
Approach	Hybrid bottom-up methodology using EU production, trade, and consumption data.

Key Segments

Product Type

• Regular/Full Fat
• Reduced Fat

Application

• Coffee-based Drinks (Barista)
• Smoothies & RTD
• Breakfast/Cereal Use
• Cooking & Baking
• Other Uses

Distribution Channel

• Food Services (HoReCa)
• Retail Stores (Brick & Mortar)
• Online Retail

Nature

• Conventional
• Organic

Countries

• Germany
• France
• Italy
• Spain
• Netherlands
• Rest of Europe

Bibliography

• International Dairy Federation (IDF). (2024). World Dairy Situation Report 2024: Lactose Market Section. IDF.
• European Pharmacopoeia Commission. (2024). European Pharmacopoeia 11th Edition: Lactose Monohydrate Monograph. EDQM.
• European Commission. (2024). Delegated Regulation (EU) 2016/127 on Infant Formula Composition Requirements. EUR-Lex.
• Codex Alimentarius Commission. (2024). Standard for Infant Formula (CXS 72-1981): Carbohydrate Source Requirements. FAO/WHO.
• European Commission. (2024). EU Milk Market Observatory: Whey Products Price Dashboard. European Commission DG Agriculture.

This bibliography is provided for reader reference. The full FMI report contains the complete reference list with primary research documentation.

This Report Addresses

• Market sizing and forecast metrics for lactose across EU end-use sectors through 2036.
• Segmentation analysis mapping adoption velocity and regulatory factors driving product migration.
• Country-level intelligence comparing growth across major EU markets.
• Regulatory compliance assessment analyzing EU classification, labelling, and authorization standards.
• Competitive posture evaluation tracking supplier dynamics and margin structures.
• Strategic procurement guidance defining supply agreements and inventory parameters.
• Supply chain vulnerability analysis identifying regulatory, origin, and seasonal risks.
• Custom data delivery: interactive dashboards, raw Excel datasets, and PDF narrative reports.